Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 3 | 2017 | 143 | 1.150 |
Why?
|
| Neuroblastoma | 3 | 2017 | 374 | 1.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2017 | 120 | 0.690 |
Why?
|
| Transcriptome | 4 | 2018 | 580 | 0.620 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2017 | 30 | 0.620 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 1384 | 0.600 |
Why?
|
| Sulfoxides | 1 | 2017 | 6 | 0.600 |
Why?
|
| Genes, myc | 1 | 2017 | 39 | 0.590 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2015 | 292 | 0.550 |
Why?
|
| Pyrimidines | 1 | 2017 | 370 | 0.480 |
Why?
|
| Porphobilinogen Synthase | 1 | 2012 | 4 | 0.450 |
Why?
|
| Genomics | 2 | 2017 | 720 | 0.440 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 296 | 0.430 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 93 | 0.420 |
Why?
|
| Immunotherapy | 2 | 2017 | 629 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 1197 | 0.410 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 183 | 0.400 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2015 | 763 | 0.400 |
Why?
|
| Hematologic Neoplasms | 1 | 2013 | 329 | 0.340 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 2426 | 0.310 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 1208 | 0.310 |
Why?
|
| Risk | 3 | 2017 | 674 | 0.300 |
Why?
|
| Transcription Factors | 2 | 2013 | 1565 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 4 | 2013 | 937 | 0.270 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 2360 | 0.260 |
Why?
|
| Gene Silencing | 2 | 2017 | 172 | 0.230 |
Why?
|
| Prognosis | 3 | 2017 | 3679 | 0.230 |
Why?
|
| Pituitary Hormones | 1 | 2002 | 7 | 0.220 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 2002 | 6 | 0.220 |
Why?
|
| Cushing Syndrome | 1 | 2002 | 24 | 0.220 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2002 | 131 | 0.210 |
Why?
|
| Cardiomegaly | 2 | 2012 | 111 | 0.200 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 536 | 0.200 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2012 | 104 | 0.200 |
Why?
|
| Circadian Rhythm | 1 | 2002 | 303 | 0.180 |
Why?
|
| Child | 5 | 2017 | 6927 | 0.180 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 427 | 0.180 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 2903 | 0.170 |
Why?
|
| Histones | 2 | 2012 | 311 | 0.170 |
Why?
|
| Mice | 9 | 2013 | 11352 | 0.150 |
Why?
|
| Acute Chest Syndrome | 1 | 2017 | 16 | 0.150 |
Why?
|
| Embryonic Stem Cells | 1 | 2017 | 78 | 0.150 |
Why?
|
| Exosomes | 1 | 2017 | 50 | 0.140 |
Why?
|
| Pharmacogenomic Testing | 1 | 2017 | 97 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2017 | 272 | 0.140 |
Why?
|
| Humans | 17 | 2018 | 86644 | 0.140 |
Why?
|
| Exons | 1 | 2017 | 450 | 0.140 |
Why?
|
| RNA Polymerase II | 2 | 2012 | 55 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2017 | 1578 | 0.130 |
Why?
|
| Animals | 10 | 2013 | 26582 | 0.130 |
Why?
|
| Protein Binding | 3 | 2013 | 1456 | 0.120 |
Why?
|
| Citric Acid | 1 | 2013 | 38 | 0.120 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2013 | 5 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2017 | 3612 | 0.110 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 30 | 0.110 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2013 | 11 | 0.110 |
Why?
|
| Adiponectin | 1 | 2013 | 24 | 0.110 |
Why?
|
| Infant | 3 | 2017 | 3047 | 0.110 |
Why?
|
| Cell Separation | 1 | 2013 | 196 | 0.110 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 47 | 0.110 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 21 | 0.110 |
Why?
|
| Burkitt Lymphoma | 1 | 2012 | 31 | 0.110 |
Why?
|
| Apoptosis | 2 | 2017 | 1683 | 0.110 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 72 | 0.110 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2012 | 28 | 0.110 |
Why?
|
| Heparin | 1 | 2013 | 175 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2012 | 79 | 0.110 |
Why?
|
| Sirtuins | 1 | 2012 | 45 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 133 | 0.110 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 113 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 114 | 0.100 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 229 | 0.100 |
Why?
|
| Allografts | 1 | 2013 | 172 | 0.100 |
Why?
|
| Eye | 1 | 2012 | 111 | 0.100 |
Why?
|
| Computational Biology | 1 | 2015 | 528 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 456 | 0.100 |
Why?
|
| Tamoxifen | 1 | 2012 | 168 | 0.100 |
Why?
|
| DNA Primers | 1 | 2012 | 543 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 153 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2013 | 141 | 0.100 |
Why?
|
| Leukemia, Myeloid | 1 | 2012 | 249 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1376 | 0.100 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2011 | 67 | 0.100 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 32 | 0.100 |
Why?
|
| Signal Transduction | 4 | 2015 | 3241 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1458 | 0.100 |
Why?
|
| Cell Line | 2 | 2012 | 2468 | 0.100 |
Why?
|
| Autophagy | 1 | 2012 | 149 | 0.100 |
Why?
|
| Software | 1 | 2015 | 654 | 0.100 |
Why?
|
| Smad3 Protein | 1 | 2010 | 15 | 0.100 |
Why?
|
| Smad2 Protein | 1 | 2010 | 17 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 878 | 0.100 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2011 | 93 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 927 | 0.090 |
Why?
|
| Genome, Human | 1 | 2015 | 756 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 125 | 0.090 |
Why?
|
| Binding Sites | 1 | 2013 | 1098 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2013 | 408 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 381 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 1204 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 322 | 0.090 |
Why?
|
| Recurrence | 1 | 2013 | 1139 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2012 | 403 | 0.090 |
Why?
|
| Protein Methyltransferases | 1 | 2009 | 14 | 0.090 |
Why?
|
| Transplantation Conditioning | 1 | 2011 | 373 | 0.090 |
Why?
|
| Graft vs Host Disease | 1 | 2011 | 365 | 0.090 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2009 | 55 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 1056 | 0.080 |
Why?
|
| Base Sequence | 1 | 2012 | 2330 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 301 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2011 | 666 | 0.080 |
Why?
|
| Disease Progression | 1 | 2013 | 1531 | 0.080 |
Why?
|
| Acetylation | 3 | 2013 | 121 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 696 | 0.080 |
Why?
|
| Age Factors | 1 | 2013 | 1851 | 0.080 |
Why?
|
| DNA Methylation | 2 | 2011 | 628 | 0.080 |
Why?
|
| Mutation | 2 | 2017 | 3968 | 0.080 |
Why?
|
| Graft Survival | 1 | 2011 | 884 | 0.080 |
Why?
|
| Time Factors | 2 | 2013 | 5210 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1830 | 0.070 |
Why?
|
| Female | 8 | 2017 | 44533 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 1464 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2012 | 1540 | 0.060 |
Why?
|
| Heart Failure | 1 | 2012 | 1204 | 0.060 |
Why?
|
| Pulsatile Flow | 1 | 2002 | 49 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2012 | 1924 | 0.050 |
Why?
|
| Adolescent | 3 | 2017 | 8981 | 0.050 |
Why?
|
| Risk Factors | 1 | 2013 | 5417 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 3092 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2002 | 263 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2012 | 498 | 0.050 |
Why?
|
| RNA Interference | 2 | 2012 | 369 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2013 | 7993 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2012 | 782 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 879 | 0.040 |
Why?
|
| Male | 6 | 2017 | 40966 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2017 | 1981 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2818 | 0.040 |
Why?
|
| Adult | 4 | 2017 | 25648 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 1565 | 0.040 |
Why?
|
| Autografts | 1 | 2017 | 28 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 479 | 0.040 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 102 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 88 | 0.040 |
Why?
|
| Anemia, Sickle Cell | 1 | 2017 | 131 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 428 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2015 | 185 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2015 | 260 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2012 | 12 | 0.030 |
Why?
|
| U937 Cells | 1 | 2012 | 32 | 0.030 |
Why?
|
| K562 Cells | 1 | 2012 | 43 | 0.030 |
Why?
|
| Pericytes | 1 | 2012 | 12 | 0.030 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2012 | 9 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2012 | 30 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2012 | 43 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 5976 | 0.030 |
Why?
|
| eIF-2 Kinase | 1 | 2012 | 46 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 77 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 30 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2012 | 39 | 0.030 |
Why?
|
| Leptin | 1 | 2013 | 105 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 228 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 187 | 0.030 |
Why?
|
| Caspases | 1 | 2012 | 155 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 62 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2012 | 83 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2012 | 252 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 114 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2012 | 129 | 0.030 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2011 | 5 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1621 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 265 | 0.030 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 30 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2011 | 15 | 0.030 |
Why?
|
| Heterozygote | 1 | 2012 | 365 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2012 | 369 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2013 | 510 | 0.030 |
Why?
|
| Body Weight | 1 | 2013 | 459 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2011 | 158 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 458 | 0.020 |
Why?
|
| Aged | 2 | 2011 | 18415 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 279 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 826 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2010 | 55 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2010 | 40 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2767 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2013 | 377 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 378 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 689 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 969 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 207 | 0.020 |
Why?
|
| Illinois | 1 | 2011 | 462 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 692 | 0.020 |
Why?
|
| Chromatin | 1 | 2012 | 380 | 0.020 |
Why?
|
| Remission Induction | 1 | 2011 | 722 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 642 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 615 | 0.020 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2009 | 12 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 996 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2009 | 32 | 0.020 |
Why?
|
| Middle Aged | 2 | 2011 | 25028 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 839 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2009 | 86 | 0.020 |
Why?
|
| Arginine | 1 | 2009 | 136 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1106 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 236 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 599 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 1538 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 1230 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1135 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 1160 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 729 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 639 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 1577 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 2378 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 1284 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1196 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 2894 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 8489 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1621 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2357 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 1749 | 0.010 |
Why?
|